Akebia Therapeutics Inc.
(AKBA)
undefined
undefined%
At close: undefined
1.84
0.00%
After-hours Dec 13, 2024, 07:52 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 42.92M | 90.47M | 149.80M | 228.70M | 147.45M | 104.64M | 70.16M | 187.34M | 49.78M | 32.78M | 21.22M | 1.64M |
Short-Term Investments | - | - | - | 39.99M | 245.00K | 217.00M | 247.64M | 73.01M | 88.68M | 76.14M | 11.34M | - |
Long-Term Investments | - | 2.70M | 2.04M | 2.04M | 2.09M | 2.46M | 1.28M | - | - | - | - | - |
Other Long-Term Assets | 12.42M | 5.37M | 49.75M | 37.98M | 75.98M | 21.80M | 2.27M | 1.28M | 1.38M | 305.00K | 1.20M | - |
Receivables | 39.29M | 41.06M | 51.58M | 26.85M | 38.86M | 16.67M | 34.22M | 33.82M | - | 48.00K | - | 85.63K |
Inventory | 15.69M | 21.76M | 38.20M | 61.02M | 116.35M | 114.25M | 1.00 | - | - | - | - | - |
Other Current Assets | 20.24M | 32.86M | 33.14M | 14.88M | 6.63M | 31.45M | 12.70M | 2.15M | 5.13M | 3.08M | 740.00K | 517.20K |
Total Current Assets | 118.15M | 184.95M | 272.01M | 371.44M | 309.53M | 468.27M | 358.36M | 296.32M | 141.02M | 110.48M | 33.43M | 2.24M |
Property-Plant & Equipment | 16.05M | 34.37M | 40.61M | 35.50M | 39.42M | 8.02M | 3.62M | 2.61M | 540.00K | 209.93K | 30.37K | - |
Goodwill & Intangibles | 95.09M | 127.14M | 163.18M | 199.22M | 346.26M | 383.21M | -1.46M | - | - | - | - | - |
Total Long-Term Assets | 123.55M | 166.88M | 253.54M | 272.70M | 461.67M | 528.26M | 5.89M | 3.90M | 1.92M | 514.93K | 1.23M | - |
Total Assets | 241.70M | 351.83M | 525.55M | 644.14M | 771.20M | 996.54M | 364.25M | 300.22M | 142.94M | 111.00M | 34.66M | 2.24M |
Account Payables | 14.63M | 18.02M | 33.59M | 41.31M | 39.22M | 42.80M | 7.00M | 2.04M | 2.31M | 2.02M | 714.00K | 417.94K |
Deferred Revenue | - | 3.74M | 20.91M | 15.21M | 39.83M | 56.98M | 84.91M | 81.97M | -8.00K | - | - | - |
Short-Term Debt | 24.04M | 36.74M | 102.34M | 5.29M | 4.99M | 15.00M | - | - | - | - | - | - |
Other Current Liabilities | 61.20M | 71.03M | 104.21M | 125.34M | 124.08M | 150.92M | 51.45M | 30.26M | 9.55M | 4.86M | 3.19M | 4.51M |
Total Current Liabilities | 99.87M | 124.76M | 256.49M | 187.15M | 208.12M | 265.69M | 144.35M | 114.27M | 11.87M | 6.88M | 3.90M | 4.92M |
Long-Term Debt | 80.14M | 120.52M | 33.70M | 121.00M | 103.33M | - | - | - | - | - | 8.00K | - |
Other Long-Term Liabilities | 48.98M | 57.47M | 139.11M | 63.03M | 31.87M | 32.58M | 2.61M | 2.51M | 74.00K | 32.00K | 0.00 | - |
Total Long-Term Liabilities | 172.42M | 217.73M | 192.60M | 209.38M | 168.33M | 94.92M | 100.57M | 117.83M | 74.00K | 32.00K | 8.00K | - |
Total Liabilities | 272.29M | 342.49M | 449.09M | 396.52M | 376.44M | 360.61M | 244.92M | 232.10M | 11.94M | 6.92M | 3.91M | 4.92M |
Total Debt | 104.18M | 99.78M | 136.05M | 126.28M | 108.32M | 15.00M | - | 14.00K | 14.00K | - | 11.92K | - |
Common Stock | 2.00K | 2.00K | 1K | 1K | 1K | 1K | - | - | - | - | 134.00 | 6.00 |
Retained Earnings | -1.61B | -1.55B | -1.46B | -1.18B | -794.05M | -514.39M | -374.05M | -297.14M | -161.39M | -100.67M | -63.71M | -59.59M |
Comprehensive Income | 6.00K | 6.00K | 6.00K | 13.00K | 0.00 | -261.00K | -442.00K | -42.00K | -234.00K | -56.00K | -1.28K | - |
Shareholders Equity | -30.58M | 9.34M | 76.46M | 247.62M | 394.76M | 635.93M | 119.33M | 68.12M | 131.00M | 104.08M | 30.76M | -2.68M |
Total Investments | 1.65M | 2.70M | 2.04M | 39.99M | 245.00K | 217.00M | 247.64M | 73.01M | 88.68M | 76.14M | 11.34M | - |